After a scheduled follow-up evaluation on Friday, President Donald Trump&#8217;s physician said Trump &#8220;remains in exceptional health&#8221; and is showing &#8220;strong cardiovascular, pulmonary, neurological and physical performance.&#8221;
Trump, 79, was at Walter Reed National Military Medical Center for about three hours and underwent lab tests and preventive health assessments. Trump&#8217;s doctor, Navy Capt. Sean Barbabella, said in a one-page memo that the president received a yearly flu shot and a COVID booster vaccine.
Barbabella noted that Trump&#8217;s cardiac age is 14 years younger than his actual age, adding that the president &#8220;continues to demonstrate excellent overall health.&#8221;
&#8220;His cardiac age &#8212; a validated measure of cardiovascular vitality via ECG &#8212; was found to be approximately 14 years younger than his chronological age,&#8221; the memo said. &#8220;He continues to maintain a demanding daily schedule without restriction.&#8221;
<blockquote class="twitter-tweet">
&#8220;President Donald J. Trump continues to demonstrate excellent overall health.&#8221;
&#8211; Captain Sean P. Barbabella, D.O. 
Physician to the President <a href="https://t.co/BfBsJTUOGh">pic.twitter.com/BfBsJTUOGh</a>
— The White House (@WhiteHouse) <a href="https://twitter.com/WhiteHouse/status/1977034436761075946?ref_src=twsrc%5Etfw">October 11, 2025</a></blockquote>
Back in July, Trump underwent medical testing and received a diagnosis of “chronic venous insufficiency” in his legs, <a href="https://www.dailywire.com/news/white-house-reveals-medical-condition-causing-swelling-in-trumps-legs">The Daily Wire</a> reported.
“I know that many in the media have been speculating about bruising on the president’s hand and also swelling in the president’s legs,” White House Press Secretary Karoline Leavitt said at the time. “So in the effort of transparency, the president wanted me to share a note from his physician with all of you today.&#8221;
<a href="https://get.dailywire.com/subscribe/plus/?utm_campaign=fall40&amp;utm_content=fallsale&amp;utm_medium=website&amp;utm_source=editorial">Get 40% off new DailyWire+ annual memberships with code FALL40 at checkout</a>
A memo from Barbabella said there was &#8220;mild swelling&#8221; in Trump&#8217;s lower legs and that the president&#8217;s concern was “thoroughly evaluated by the White House medical unit,” out of an “abundance of caution.”
Ultrasounds to assess blood flow in both of his legs found “chronic venous insufficiency,” Leavitt relayed. Barbabella called this a “benign, common condition, particularly in individuals over the age of 70.”
Trump&#8217;s health update comes as his predecessor, former President Joe Biden, <a href="https://www.dailywire.com/news/biden-team-provides-update-on-cancer-battle-radiation-therapy?author=Amanda+Prestigiacomo&amp;category=News&amp;elementPosition=0&amp;row=0&amp;rowType=Vertical+List&amp;title=Biden+Team+Provides+Update+On+Cancer+Battle%2C+Radiation+Therapy">released</a> an update on his cancer battle. Biden is receiving radiation treatment for about five weeks for his advanced prostate cancer, according to a spokesperson.
“As part of a treatment plan for prostate cancer, President Biden is currently undergoing radiation therapy and hormone treatment,” the spokesperson said.
Biden has been taking the pill form of a hormone medication, <a href="https://www.nbcnews.com/politics/joe-biden/former-president-joe-biden-radiation-therapy-prostate-cancer-rcna237019?cid=sm_npd_nn_tw_ma&amp;taid=68ea5740399eb60001a9aacb&amp;utm_campaign=trueanthem&amp;utm_medium=social&amp;utm_source=twitter" target="_blank" rel="noopener">according</a> to NBC News, and the former president&#8217;s team <a href="https://nypost.com/2025/10/11/us-news/joe-biden-undergoing-radiation-in-new-phase-of-prostate-cancer-treatment-spokesperson-says/?utm_source=twitter&amp;utm_campaign=nypost&amp;utm_medium=social" target="_blank" rel="noopener">says</a> Biden is “doing well.”
The 82-year-old first disclosed his aggressive cancer diagnosis back in May, mere months after he left office. At the time, it was reported that Biden had metastatic prostate cancer that had moved from the prostate all the way to his bones.
Related: <a href="https://www.dailywire.com/news/biden-team-provides-update-on-cancer-battle-radiation-therapy?author=Amanda+Prestigiacomo&amp;category=News&amp;elementPosition=0&amp;row=0&amp;rowType=Vertical+List&amp;title=Biden+Team+Provides+Update+On+Cancer+Battle%2C+Radiation+Therapy">Biden Team Provides Update On Cancer Battle, Radiation Therapy</a>

Donald Trump

White House Releases Trump’s ‘Excellent’ Health Exam Summary

Executive

Health

Joe Biden

Politics

White House

Former President Joe Biden is receiving radiation treatment for about five weeks for his advanced prostate cancer, according to a spokesperson.
&#8220;As part of a treatment plan for prostate cancer, President Biden is currently undergoing radiation therapy and hormone treatment,&#8221; the spokesperson said.
Biden has been taking a pill form of hormone medication, <a href="https://www.nbcnews.com/politics/joe-biden/former-president-joe-biden-radiation-therapy-prostate-cancer-rcna237019?cid=sm_npd_nn_tw_ma&amp;taid=68ea5740399eb60001a9aacb&amp;utm_campaign=trueanthem&amp;utm_medium=social&amp;utm_source=twitter">according</a> to NBC News.
The 82-year-old&#8217;s team <a href="https://nypost.com/2025/10/11/us-news/joe-biden-undergoing-radiation-in-new-phase-of-prostate-cancer-treatment-spokesperson-says/?utm_source=twitter&amp;utm_campaign=nypost&amp;utm_medium=social">says</a> Biden is &#8220;doing well.&#8221;
Biden first disclosed his aggressive cancer diagnosis back in May, mere months after he left office. At the time, it was reported that Biden had metastatic prostate cancer that had moved from the prostate all the way to his bones.
&#8220;Cancer touches us all,&#8221; Biden said on X, back in May. &#8220;Like so many of you, Jill and I have learned that we are strongest in the broken places. Thank you for lifting us up with love and support.&#8221;
<blockquote class="twitter-tweet">
Cancer touches us all. Like so many of you, Jill and I have learned that we are strongest in the broken places. Thank you for lifting us up with love and support. <a href="https://t.co/oSS1vGIiwU">pic.twitter.com/oSS1vGIiwU</a>
— Joe Biden (@JoeBiden) <a href="https://twitter.com/JoeBiden/status/1924427587582828753?ref_src=twsrc%5Etfw">May 19, 2025</a></blockquote>
The diagnosis brought well-wishes and prayers from both sides of the political aisle, but it also raised questions &#8212; specifically, when did Biden insiders know about the cancer and how long did they wait to tell the public?
As noted by Daily Wire Editor Emeritus <a href="https://www.dailywire.com/news/biden-was-senile-had-cancer-and-they-knew">Ben Shapiro</a>, prostate cancer is not a fast-moving cancer, and usually takes years to develop to the point of metastasis.
<a href="https://get.dailywire.com/subscribe/plus/?utm_campaign=fall40&amp;utm_content=fallsale&amp;utm_medium=website&amp;utm_source=editorial">Get 40% off new DailyWire+ annual memberships with code FALL40 at checkout</a>
There have also been questions surrounding Biden&#8217;s mental fitness and his use of the &#8220;autopen&#8221; while he was serving as president.
In June, President Donald Trump <a href="https://www.dailywire.com/news/trump-orders-investigation-into-biden-autopen-scandal">signed a memo</a> ordering an investigation into the matter, specifically calling for Counsel to the President to look into whether aides improperly used an autopen for executive actions in an effort to conceal Biden’s health issues while in office.
The memo directs officials to determine if “certain individuals conspired to deceive the public about Biden’s mental state and unconstitutionally exercise the authorities and responsibilities of the President.”
Additionally, there&#8217;s a House Oversight Committee investigation into the matter.
Related: <a href="https://www.dailywire.com/news/biden-was-senile-had-cancer-and-they-knew">Biden Was Senile, Had Cancer, And They Knew</a>

President Biden Hosts Presidential Citizens Medal Ceremony

Biden Team Provides Update On Cancer Battle, Radiation Therapy

Biden Provides Update On Cancer Battle 

Biden Administration

Cancer

The U.S. Food and Drug Administration confirmed on Friday that toxic cough syrups linked to children&#8217;s deaths in India had not been shipped to the United States.
The World Health Organization has said India has a &#8220;regulatory gap&#8221; in screening locally sold syrup medicines.
The U.S. FDA said it was aware of news reports of devastating, ongoing diethylene glycol and ethylene glycol contamination in children&#8217;s cough and cold medicine in India.
Indian authorities advised the public to avoid two more brands of cough syrup on Wednesday following the deaths of 17 children under age five, linked to a toxic ingredient.
<a href="https://get.dailywire.com/subscribe/plus/?utm_campaign=fall40&amp;utm_content=fallsale&amp;utm_medium=website&amp;utm_source=editorial">Get 40% off new DailyWire+ annual memberships with code FALL40 at checkout</a>
The children died in India over the past month after consuming cough medicine containing toxic diethylene glycol in quantities nearly 500 times the permissible limit, officials said. The deaths were all linked to the Coldrif medicine brand, which was banned after a test confirmed the presence of the chemical on October 2.
India&#8217;s health authority, the Central Drugs Standard Control Organization, informed the U.S. regulator that these products were not exported from India to any other country, the FDA said.
The FDA also said it remains vigilant to prevent contaminated drugs from entering the U.S. and asked manufacturers to ensure that drugs marketed in the U.S. are safe and of the highest quality.
(Reporting by Sneha S K in Bengaluru; Editing by Pooja Desai)

Cough Syrup

Cough Syrups Linked To Child Deaths Not Shipped To U.S., FDA Makes Clear

India

Prescription Drugs

World

President Donald Trump unveiled a deal with U.K.-based drugmaker AstraZeneca on Friday under which the company will sell some medicines at a discount to the government&#8217;s Medicaid health plan in exchange for tariff relief, similar to a drug pricing pact reached last week with Pfizer.
The deals set a framework the White House will use to try to reach its goal of lowering U.S. prescription medicine prices. The president sent letters to 17 leading drugmakers in July telling them to slash prices. Pfizer and Astra are the first two companies to reach a deal with the administration.
AstraZeneca will also offer some of its drugs at up to 80% off their list price through the TrumpRx website planned for next year, CEO Pascal Soriot said at an event in the Oval Office.
He said the company will receive a three-year tariff exemption &#8220;to localize the remainder of our products.&#8221;
U.S. patients currently pay by far the most for prescription medicines, often nearly three times more than in other developed nations, and Trump has been pressuring drugmakers to lower their prices to what patients pay elsewhere or face stiff tariffs.
Last month, Trump threatened 100% tariffs, ratcheting up pressure on the pharmaceutical industry to agree to price cuts and shift manufacturing to the U.S., after negotiations broke down earlier this year, lobbyists and executives told Reuters following the Pfizer deal.
More than 70 million people are covered by Medicaid, the state and federal government program for low-income people. Drug spending in that program is dwarfed by that of Medicare, which covers people aged 65 and older or those with disabilities and is not included in Friday&#8217;s announcement.
<a href="https://get.dailywire.com/subscribe/plus/?utm_campaign=fall40&amp;utm_content=fallsale&amp;utm_medium=website&amp;utm_source=editorial">Get 40% off new DailyWire+ annual memberships with code FALL40 at checkout</a>
Medicare&#8217;s drug spending reached $216 billion in 2021, while Medicaid&#8217;s gross spending was around $80 billion.
The Medicaid program already receives the lowest drug prices in the U.S., so the additional savings may be modest, said Craig Garthwaite, a professor at Northwestern University&#8217;s Kellogg School of Management.
&#8220;If you look at AstraZeneca&#8217;s portfolio, I don&#8217;t think there are a bunch of drugs that exist where that&#8217;s going to involve them giving a very big discount to Medicaid,&#8221; Garthwaite said.
AstraZeneca&#8217;s Pfizer‑like deal may spare it tariffs, but will not move the needle on U.S. rising health insurance premiums and out‑of‑pocket drug costs, said Rena Conti, an associate professor at Boston University.
&#8220;It&#8217;s good for the companies, and has very uncertain if any benefit for Americans struggling with the affordability of prescription drugs,&#8221; Conti said.
Soriot has worked to keep his company close to Washington while pursuing its growth strategy.
AstraZeneca in July announced it will invest $50 billion in U.S. manufacturing and research and development by 2030. It will build its biggest site worldwide in Virginia, and expand facilities in five other U.S. states.
In September, the company announced it will sell its diabetes and asthma drugs direct to cash-paying U.S. patients at a discount of up to 70% off list prices, another move in response to Trump&#8217;s pressure campaign.
Soriot this year has played up the company&#8217;s U.S. credentials. He described the Anglo-Swedish firm as a &#8220;very American company,&#8221; highlighting its identity shift toward its largest market. AstraZeneca will list its shares in the United States as well as its current markets in the UK and Europe.
(Reporting by Steve Holland in Washington and Michael Erman in New Jersey; Additional reporting by Jarrett Renshaw and Ahmed Aboulenein in Washington, Maggie Fick in London, Patrick Wingrove in New York and Mariam E Sunny in Bengaluru; Editing by Caroline Humer and Bill Berkrot)

Trump Announces U.S. Drug Pricing Deal With AstraZeneca

Economy

Health Care

Pfizer

U.K.

A Los Angeles jury ordered Johnson &amp; Johnson to pay $966 million to the family of a woman who died from mesothelioma, finding the company liable in the latest trial alleging its talc products cause cancer.
The family of Mae Moore, a California resident who died at age 88 in 2021, sued the company the same year, claiming J&amp;J&#8217;s talc baby powder products contained asbestos fibers that caused her rare cancer. The jury late on Monday ordered J&amp;J to pay $16 million in compensatory damages and $950 million in punitive damages, according to court filings.
The verdict could be reduced on appeal as the U.S. Supreme Court has found that punitive damages should generally be no more than nine times compensatory damages.
Erik Haas, Johnson &amp; Johnson&#8217;s worldwide vice president of litigation, said in a statement that the company plans to immediately appeal, calling the verdict &#8220;egregious and unconstitutional.&#8221;
&#8220;The plaintiff lawyers in this Moore case based their arguments on ‘junk science’ that never should have been presented to the jury,&#8221; Haas said.
The company has said its products are safe, do not contain asbestos, and do not cause cancer. J&amp;J stopped selling talc-based baby powder in the U.S. in 2020, switching to a cornstarch product. Mesothelioma has been linked to asbestos exposure.
Trey Branham, one of the attorneys representing Moore&#8217;s family, said after the verdict that his team is “hopeful that Johnson &amp; Johnson will finally accept responsibility for these senseless deaths.”
J&amp;J is facing lawsuits from more than 67,000 plaintiffs who say they were diagnosed with cancer after using baby powder and other talc products, according to court filings. The number of lawsuits alleging talc caused mesothelioma is a small subset of these cases, with the vast majority involving ovarian cancer claims.
<a href="https://get.dailywire.com/subscribe/plus/?utm_campaign=fall40&amp;utm_content=fallsale&amp;utm_medium=website&amp;utm_source=editorial">Get 40% off new DailyWire+ annual memberships with code FALL40 at checkout</a>
J&amp;J has sought to resolve the litigation through bankruptcy, a proposal that has been rejected three times by federal courts.
Lawsuits alleging talc caused mesothelioma were not part of the last bankruptcy proposal. The company has previously settled some of those claims but has not struck a nationwide settlement, so many lawsuits over mesothelioma have proceeded to trial in state courts in recent months.
In the past year, J&amp;J has been hit with several substantial verdicts in mesothelioma cases, but Monday&#8217;s is among the largest. The company has won some of the mesothelioma trials, including last week in South Carolina, where a jury found J&amp;J not liable.
The company has been successful in reducing some of the awards on appeal, including in one Oregon case where a state judge granted J&amp;J&#8217;s motion to throw out a $260 million verdict and hold a new trial.
(Reporting by Diana Novak Jones; Editing by Alexia Garamfalvi, Rod Nickel and Bill Berkrot)

Johnson & Johnson

Johnson & Johnson Ordered To Pay Staggering Sum In Talc Cancer Case

Courts

Johnson &amp; Johnson

U.S.

The U.S. Food and Drug Administration said on Friday it has launched a new pilot program to speed up the review process for generic drugs that are tested and manufactured entirely in the United States.
The program is designed to encourage companies to invest in domestic drug production and research by offering faster approvals for products made with U.S.-sourced ingredients and tested within the country.
Earlier this week, the FDA held a public meeting to discuss its broader efforts to support U.S. pharmaceutical manufacturing, including the PreCheck program, which aims to help set up high-priority drug facilities more quickly.
The FDA said these steps will help strengthen the U.S. drug supply chain and bring high-quality, U.S.-made generic drugs to market more quickly.
More than half of the pharmaceuticals distributed in the United States are made overseas, according to the health regulator.
As of 2025, only 9% of companies that produce the key ingredients in drugs &#8211; known as active pharmaceutical ingredients &#8211; are based in the U.S., compared to 22% in China and 44% in India, the FDA said.
<a href="https://get.dailywire.com/subscribe/plus/?utm_campaign=fall40&amp;utm_content=fallsale&amp;utm_medium=website&amp;utm_source=editorial">Get 40% off new DailyWire+ annual memberships with code FALL40 at checkout</a>
&#8220;Over-reliance on foreign drug manufacturing and testing creates risks both to national security and patient access, and undermines investments in U.S. research, manufacturing and production,&#8221; said George Tidmarsh, Director of FDA&#8217;s Center for Drug Evaluation and Research.
&#8220;It also slows down reviews and costs taxpayers more money,&#8221; he added.
The FDA also noted many important studies used to approve drugs &#8211; including tests to show that generic drugs work the same as brand-name ones &#8211; are now often done outside the U.S., which is weakening the country&#8217;s ability to lead in drug research and development.
(Reporting by Siddhi Mahatole in Bengaluru; Editing by Shailesh Kuber)

Prescription drugs

FDA Launches Pilot Program To Fast-Track Review Of Generic Drugs Made In U.S.

Trump Administration

In a sweeping shift to align with the Trump administration’s “Make America Healthy Again” agenda, grocery giant Walmart will drop synthetic dyes and more than 30 other additives — including artificial sweeteners and preservatives — from all of its store brands.
Walmart&#8217;s brands, including Great Value, Marketside, Freshness Guaranteed, and Bettergoods, are all getting the MAHA makeover, according to the retailer. The changes will affect more than 1,000 products, including salty snacks, sweet treats, salad dressings, and power drinks.
The reformulated products are expected to hit the shelves within a matter of months, and all changes are anticipated to be fully implemented by January 2027.
&#8220;Our customers have told us that they want products made with simpler, more familiar ingredients — and we&#8217;ve listened,&#8221; Walmart U.S. CEO John Furner <a href="https://corporate.walmart.com/news/2025/10/01/walmart-u-s-moves-to-eliminate-synthetic-dyes-across-all-private-brand-food-products">said</a>. &#8220;By eliminating synthetic dyes and other ingredients, we’re reinforcing our promise to deliver affordable food that families can feel good about.”
<a class="c-link c-link--focus-visible" href="https://get.dailywire.com/subscribe/plus/?utm_campaign=fall40&amp;utm_content=fallsale&amp;utm_medium=website&amp;utm_source=editorial" target="_blank" rel="noopener noreferrer" data-stringify-link="https://get.dailywire.com/subscribe/plus/?utm_campaign=fall40&amp;utm_content=fallsale&amp;utm_medium=website&amp;utm_source=editorial" data-sk="tooltip_parent" aria-describedby="sk-tooltip-246585">Get 40% off new DailyWire+ annual memberships with code FALL40 at checkout!</a> 
The changes are expected to have a significant impact on the American family, as Walmart plays a massive role in national grocery shopping. Just last year, the company netted $276 billion in grocery sales, for example.
Health and Human Services (HHS) Secretary Robert F. Kennedy Jr., who&#8217;s viewed as the figurehead of the MAHA movement, has been working with private companies to end the use of synthetic food dyes and other controversial additives. So far, major companies like PepsiCo, Tyson Foods, and Sam&#8217;s Club, among others, have signed on to the mission.
<blockquote class="twitter-tweet">
🇺🇸 MAKE AMERICA HEALTHY AGAIN!
The Trump Administration delivers on MAHA: Dozens of ice cream brands drop artificial colors, joining major companies in improving our food supply! 💪⬇️ <a href="https://t.co/NdR4u4pAya">pic.twitter.com/NdR4u4pAya</a>
— The White House (@WhiteHouse) <a href="https://twitter.com/WhiteHouse/status/1945156962183749905?ref_src=twsrc%5Etfw">July 15, 2025</a></blockquote>
In addition to working with major food brands, HHS has teamed up with the Department of Agriculture to limit <a href="https://www.dailywire.com/news/why-can-food-stamps-buy-junk-food-how-doge-could-save-billions-and-maha" target="_blank" rel="noopener">food stamp</a> purchases to healthier options, generally cutting out sugary drinks and candy.
So far, at least a dozen states have had waivers authorized by Agriculture Secretary <a href="https://www.dailywire.com/news/no-amnesty-trump-usda-chief-address-deportations-of-illegal-farm-workers" target="_blank" rel="noopener">Brooke Rollins</a> to make the changes to the Supplemental Nutrition Assistance Program (SNAP).
Back in August, Kennedy reaffirmed his message that taxpayers should not be forced to pay for unhealthy foods like soda and candy, which he says are fueling the obesity epidemic in the United States and making Americans sick.
“We are spending $405 million a day on SNAP and about 10% is going to sugary drinks, and if you add candies to that, it’s about 13-17%,&#8221; he said.
“We all believe in free choice,” the secretary emphasized. “We live in a democracy — people can make their own choice about what they are going to buy and what they are not going to buy. If you want to buy a sugary soda, you should be able to do that, but the U.S. taxpayer should not pay for it.”
“U.S. taxpayers should not be paying to feed the poorest kids in the country food that will give them diabetes,” RFK added.
<blockquote class="twitter-tweet" data-media-max-width="560">
🚨 BREAKING: Secretary RFK Jr. says he is officially moving to BAN food stamps from being used for soda
FINALLY!
&#8220;The U.S. Taxpayer should NOT be paying to feed the poorest kids in the country food that will give them diabetes.&#8221;
&#8220;We are spending $405 MILLION a day on SNAP..… <a href="https://t.co/jjsmZ8DrGE">pic.twitter.com/jjsmZ8DrGE</a>
— Nick Sortor (@nicksortor) <a href="https://twitter.com/nicksortor/status/1952449669163839580?ref_src=twsrc%5Etfw">August 4, 2025</a></blockquote>
Related: <a href="https://www.dailywire.com/news/more-maha-wins-12-states-cutting-soda-candy-from-food-stamps">More MAHA Wins: 12 States Cutting Soda, Candy From Food Stamps</a>

US-ECONOMY-EARNINGS-WALMART

Major MAHA Win: Walmart Cuts Dyes And Dangerous Additives From Store Brands

brooke rollins

Business

MAHA

Robert F. Kennedy Jr.

Walmart

President Donald Trump announced on Tuesday that popular medications will be offered at massively discounted prices — known as &#8220;most-favored-nation&#8221; prices — as pharmaceutical behemoth Pfizer commits to a $70 billion investment to manufacture drugs in the U.S.
<blockquote class="twitter-tweet">
President Trump: &#8220;All new medications introduced by Pfizer to the American market will be sold at the reduced, most favored nation cost.&#8221; <a href="https://t.co/S2CQxh7PKC">pic.twitter.com/S2CQxh7PKC</a>
— CSPAN (@cspan) <a href="https://twitter.com/cspan/status/1973055450980503972?ref_src=twsrc%5Etfw">September 30, 2025</a></blockquote>
A new website, called TrumpRX, will allow Americans to purchase drugs directly from the government rather than going through insurance. Virtually all drugs will be discounted on TrumpRX, the White House said.
Pfizer stepped up with a $70 billion investment, a shift toward making drugs in the U.S., which the Trump administration has addressed as a national security issue. 
The company is also offering all medications to Medicaid at most favored nations prices &#8212; which are prices comparable to or less than the cost of other nations&#8217; drug prices. Additionally, all new medications will be offered at most-favored-nation prices.
<a href="https://get.dailywire.com/subscribe/plus/?utm_campaign=fall40&amp;utm_content=fallsale&amp;utm_medium=website&amp;utm_source=editorial">Get 40% off new DailyWire+ annual memberships with code FALL40 at checkout</a>
Dermatitis medication, for example, will be discounted by 80% &#8212; and that refers to the net price, which is what consumers are actually paying. Meds for post-menopausal osteoporosis, which is extremely common, will be discounted by 85%. Migraine medication and rheumatoid arthritis drugs will be discounted by 50% and 40%, respectively.
<blockquote class="twitter-tweet">
PROMISES MADE, PROMISES KEPT: President Trump Delivers LOWER DRUG PRICES for Americans <a href="https://t.co/nA4tPrmcXt">pic.twitter.com/nA4tPrmcXt</a>
— Rapid Response 47 (@RapidResponse47) <a href="https://twitter.com/RapidResponse47/status/1973062430591692829?ref_src=twsrc%5Etfw">September 30, 2025</a></blockquote>
Health officials, including Food and Drug Administration (FDA) Commissioner Dr. Marty Makary, emphasized that research and development will not stop, but instead, will no longer be funded by only American citizens while the rest of the world benefits.
Makary, for instance, called the changes the &#8220;end of the great American ripoff.&#8221; He noted that drug price offsets will be directed to developed nations like France, Germany, and the U.K.
&#8220;Today marks the end of the great American ripoff, and it also marks the beginning of the end of a great American tragedy, something I’ve seen as a physician at the bedside — patients getting spun up into a financial rage &#8230; to try to get enough money to pay for a drug &#8230; a drug that&#8217;s five or ten times more expensive than the same drug in France or Germany or the U.K.,&#8221; he said.
<blockquote class="twitter-tweet" data-media-max-width="560">
.<a href="https://twitter.com/DrMakaryFDA?ref_src=twsrc%5Etfw">@DrMakaryFDA</a>: &#8220;Today marks the the beginning of the end of the great American rip off, and it also marks the beginning of the end of a great American tragedy; something I’ve seen as a physician at the bedside — patients getting spun up into a financial rage&#8230; to try to get… <a href="https://t.co/SD0iKsZR2B">pic.twitter.com/SD0iKsZR2B</a>
— Rapid Response 47 (@RapidResponse47) <a href="https://twitter.com/RapidResponse47/status/1973063636395373048?ref_src=twsrc%5Etfw">September 30, 2025</a></blockquote>
Dr. Mehmet Oz, who is the administrator of the Centers for Medicare &amp; Medicaid Services (CMS), echoed the sentiment, noting that the administration is &#8220;protecting medical advances for the future, while at the same time securing the drug prices Americans want, today.&#8221;
<blockquote class="twitter-tweet">
.<a href="https://twitter.com/DrOzCMS?ref_src=twsrc%5Etfw">@DrOzCMS</a>: &#8220;In July, President Trump demanded that manufacturers make a firm commitment to lower their prices “or else.” Last week, we made a major breakthrough. Protecting medical advances for the future, while at the same time securing the drug prices Americans want today.&#8221; <a href="https://t.co/56dvAt1OHi">pic.twitter.com/56dvAt1OHi</a>
— HHS.gov (@HHSGov) <a href="https://twitter.com/HHSGov/status/1973065918897881436?ref_src=twsrc%5Etfw">September 30, 2025</a></blockquote>
Trump announced his &#8220;most favored nation&#8221; pricing plans at the end of July, promising to end &#8220;global freeloading&#8221; by other developed nations. The president suggested he would use tariffs and all other &#8220;tools&#8221; available to make sure all companies provide Americans with most-favored-nation prices.
Related: <a href="https://www.dailywire.com/news/trump-signs-order-to-reduce-drug-prices-tells-rest-of-world-to-pay-up">Trump Signs Order To Reduce Drug Prices, Tells Rest Of World To Pay Up</a>

‘End Of Great American Ripoff’: Trump Makes Major Drug Price Announcement

Drugmaker Bristol Myers Squibb is set to release a new schizophrenia treatment in the United Kingdom for the same price it’s listed for in the United States, a decision that will certainly please those in the White House who have fought to get Americans the same prices offered overseas.
The announcement, made by Bristol on Monday, follows a push from President Donald Trump for U.S. drugmakers to lower prescription drugs for Americans to the greatest extent possible. Bristol’s approach to the United Kingdom market aligns with the White House’s strategy to secure lower drug prices in the United States.
The pharmaceutical company has never before brought its price for a drug to parity across the United States and the United Kingdom. Adam Lenkowsky, chief commercialization officer at Bristol, said that the drug company is prepared to pull its drug, Cobenfy, from the European nation&#8217;s market if the relevant government authorities do not agree to the price listed in the United States, at $1,850 a month.
“Our intention is to work with NICE and NHS to make this medicine available, but we are prepared to make the difficult decision to walk away if they cannot better recognize the value our medicine brings to patients and society,” Lenkowsky said in a statement.
“We agree with the Trump Administration that other countries need to pay their fair share,” he added.
Cobenfy has not yet been approved for sale in the United Kingdom. Bristol plans to file for approval in the coming weeks and expects to receive approval sometime next year, according to the <a href="https://www.ft.com/content/0913ee5f-1631-4e1b-8bd8-99ce2c9dd64f">Financial Times</a>.
Last year, the research group RAND <a href="https://www.rand.org/news/press/2024/02/01.html">found</a> that Americans pay significantly more for prescription drugs than other countries. The research pegged the inflated price at 2.78 times what is charged in other countries.
The Trump administration is determined to end that trend, and has pointed to drug manufacturers.
“The United States has less than five percent of the world’s population and yet funds around three quarters of global pharmaceutical profits,” a May 12 White House <a href="https://www.whitehouse.gov/presidential-actions/2025/05/delivering-most-favored-nation-prescription-drug-pricing-to-american-patients/">executive order</a> on drug prices says. “This egregious imbalance is orchestrated through a purposeful scheme in which drug manufacturers deeply discount their products to access foreign markets, and subsidize that decrease through enormously high prices in the United States.”
The order aims to pressure drugmakers to push for parity between prices for its drugs in the United States and elsewhere in the world. The president last week said that other countries have treated Americans unfairly when it comes to drug prices.
“For years, we&#8217;ve been paying for a pill $100 and they&#8217;re paying $10,” the president said on Fox News last week. Trump suggested he intends to pressure other countries into raising drug prices to offset the costs of making new drugs for Americans.
“The drug companies agree that I&#8217;m right, and the countries, if they don’t agree, I’ll use tariffs to get them to agree,” Trump said. “We&#8217;re going to be reducing drug costs over the next year, year and a half by not 50% or 60%, by 1,000% … You&#8217;re talking about a monumental change in health care that&#8217;s going to affect Medicare, Medicaid, even Social Security.”
<blockquote class="twitter-tweet">
.<a href="https://twitter.com/POTUS?ref_src=twsrc%5Etfw">@POTUS</a>: &#8220;For years, we&#8217;ve been paying sometimes for a pill, $100, and [other countries] are paying $10&#8230; We&#8217;re going to be reducing drug costs over the next year, year and a half&#8230; You&#8217;re talking about a monumental change in healthcare.&#8221; <a href="https://t.co/Pxnj8vU1hc">pic.twitter.com/Pxnj8vU1hc</a>
— Rapid Response 47 (@RapidResponse47) <a href="https://twitter.com/RapidResponse47/status/1968758480476528710?ref_src=twsrc%5Etfw">September 18, 2025</a></blockquote>

UK Hosts President Trump And First Lady Melania Trump For State Visit – Day Three

Trump Push Pays Off: Pharma Giant Says Brits Must Pay Same Price As Americans For New Drug

Big Pharma

Pharmaceuticals

United Kingdom

United States

On Monday, President Donald Trump and Health and Human Services (HHS) Secretary Robert F. Kennedy Jr. <a href="https://www.hhs.gov/press-room/autism-announcement-fact-sheet.html">announced findings into the concerning spike in national autism rates</a>, labeling one medication as a potential cause of autism, and another as a potential treatment.
It was announced that the use of acetaminophen during pregnancy is tied to an increased risk of autism. Acetaminophen is the active ingredient in Tylenol, one of the most widely used medications globally for pain relief and fever reduction. 
&#8220;Taking Tylenol is not good. I&#8217;ll say it. It&#8217;s not good,&#8221; Trump said, noting that it might be necessary if a pregnant woman spikes a very high fever. &#8220;There&#8217;s a lot of common sense in this.&#8221;
Trump also talked about vaccinations, saying he believes vaccines need to be spread out over a child&#8217;s life, suggesting what&#8217;s known as a &#8220;delayed schedule.&#8221; Kennedy said later in the presser that HHS is also looking at vaccinations in connection to spiked autism rates.
<blockquote class="twitter-tweet" data-media-max-width="560">
🚨 BREAKING: President Trump just announced a link between TYLENOL and AUTISM — especially when taken during pregnancy
FDA is now recommending pregnant women don’t take Tylenol except in cases of extremely high fevers
Nor should Tylenol be frequently administered to young… <a href="https://t.co/odBhSl7pgZ">pic.twitter.com/odBhSl7pgZ</a>
— Nick Sortor (@nicksortor) <a href="https://twitter.com/nicksortor/status/1970230953776943321?ref_src=twsrc%5Etfw">September 22, 2025</a></blockquote>
Kenvue, the maker of Tylenol, <a href="https://www.axios.com/2025/09/22/trump-tylenol-autism-announcement-kenvue">said</a> in a statement, &#8220;We believe independent, sound science clearly shows that taking acetaminophen does not cause autism. We strongly disagree with any suggestion otherwise and are deeply concerned with the health risk this poses for expecting mothers.&#8221;
Since early September, the Kenvue stock has <a href="https://economictimes.indiatimes.com/news/international/us/trump-admin-report-linking-tylenol-to-autism-sends-kenvue-stock-sliding/articleshow/124049521.cms?utm_source=chatgpt.com&amp;from=mdr">dropped</a> around 15%.
It was also revealed that the drug leucovorin, also known as folinic acid, can potentially help treat autism symptoms. A physician will need to prescribe the drug for this use.
The Daily Wire&#8217;s Morning Wire podcast host Georgia Howe spoke to FDA Commissioner Dr. Marty Makary on Monday about this announcement. He emphasized that it&#8217;s vitally important to let the public know about this potential association.
“We have an epidemic of autism that has increased 400% in the recent decades and we don&#8217;t have a known cause,&#8221; he explained. &#8220;Now this may be a cause, but when you have enough evidence to suggest an association and you have no other plausible cause, we have a duty to notify parents and doctors.”
Makary has already sent out a “Dear doctor” letter to all U.S. physicians, he said.
<blockquote class="twitter-tweet">
The Trump Administration&#8217;s Autism Action Plan <a href="https://t.co/5aY5huzg8x">pic.twitter.com/5aY5huzg8x</a>
— Rapid Response 47 (@RapidResponse47) <a href="https://twitter.com/RapidResponse47/status/1970230808968602042?ref_src=twsrc%5Etfw">September 22, 2025</a></blockquote>
&#8220;We now have good data from large studies and the Harvard School of Public Health Dean has made a very conclusive statement that he believes the association is causal,&#8221; Makary explained. &#8220;So when you have that weight of evidence, you have to take it seriously and err on the side of safety, especially since the vast majority of low grade fevers do not need to be treated.”
On the issue of treating autism symptoms with leucovorin, Makary said the drug has been around for nearly a century. However, &#8220;only recently have we recognized that some kids with autism actually have an autoimmune disease,&#8221; he explained. &#8220;The mechanism may be that the body is creating antibodies that block the folate receptors on their brain, restricting the ability of folate to get into the cerebrum. And so what that does is it actually creates a situation where you could have high levels of folate in your diet.&#8221;
Back in April, Kennedy promised his findings on autism would be dropped this month. He said at the time that new data showed that autism now affects 1 in 31 children in the U.S. – that’s nearly five times higher than when the CDC started these surveys back in 1992. Even more troubling, Kennedy also said a lot of these cases are now severe. “25% of the kids diagnosed with autism are non-verbal, non-toilet trained, have other stereotypical features: head banging, tactile and light sensitivities, stimming, toe-walking, etc.,&#8221; he said.
“Secretary Kennedy is asking questions that the American people are asking,&#8221; Makary told Morning Wire. &#8220;And so we have this odd new political landscape that&#8217;s penetrated science where you&#8217;re supposedly not allowed to ask certain questions. It&#8217;s created a tremendous amount of distrust. But I can tell you the purpose of science itself is to investigate questions.&#8221;
You can watch the announcement below:
<blockquote class="twitter-tweet">
Today, President Trump and RFK Jr. announce what they describe as a historic autism breakthrough—linking prenatal medication use to increased risk and proposing a new treatment path. This unprecedented claim could reshape medicine and ignite fierce debate. <a href="https://t.co/v0fo5xyZ3w">https://t.co/v0fo5xyZ3w</a>
— Daily Wire (@realDailyWire) <a href="https://twitter.com/realDailyWire/status/1970228989890277443?ref_src=twsrc%5Etfw">September 22, 2025</a></blockquote>

Potential Cause, Treatment Of Autism Revealed By Trump, RFK Jr.

Tylenol

President Donald Trump said on Sunday that he will be making a major announcement on the autism research undertaken by Robert F. Kennedy Jr.&#8217;s Department of Health and Human Services.
&#8220;I think we&#8217;ve found an answer to autism – autism. How about that?&#8221; Trump said to tens of thousands of Americans gathered for a Charlie Kirk memorial service.
<blockquote class="twitter-tweet" data-media-max-width="560">
JUST IN &#8211; Trump says tomorrow will be the &#8220;biggest announcement medically&#8221; in the history of U.S., &#8220;I think we&#8217;ve found an answer to autism.&#8221; <a href="https://t.co/e1WrejfsfH">pic.twitter.com/e1WrejfsfH</a>
— Disclose.tv (@disclosetv) <a href="https://twitter.com/disclosetv/status/1969896398188687496?ref_src=twsrc%5Etfw">September 21, 2025</a></blockquote>
The announcement, set for Monday at 4 p.m., is expected to reveal one medication as a potential cause of autism, and another as a potential treatment.
Reports suggest Trump and Kennedy will announce that Tylenol use during early pregnancy is linked to autism. Rates of the disorder have skyrocketed in recent years, now affecting 1 in 31 children in the U.S. An August review from Mount Sinai and Harvard researchers seems to tie Tylenol to this increased risk. 
However, the CEO of Kenvue, which makes Tylenol, has denied the association and maintains that Tylenol is a safe option for pregnant women.
The administration is also expected to announce that folinic acid could help treat autism symptoms in kids. 
In April, Kennedy promised his findings on autism would be dropped this month. He said at the time that new data showed that autism now affects 1 in 31 children in the U.S. – that’s nearly five times higher than when the Centers for Disease Control and Prevention (CDC) started such surveys back in 1992. Just two years ago, the prevalence was 1 in 36 children.
Even more troubling, Kennedy also <a href="https://www.youtube.com/watch?v=yly3zpXqa2s">said</a> a lot of these cases are now severe. &#8220;25% of the kids diagnosed with autism are non-verbal, non-toilet trained, have other stereotypical features: head banging, tactile and light sensitivities, stimming, toe-walking, etc.,&#8221; the secretary explained.
<blockquote class="twitter-tweet" data-media-max-width="560">
🚨 RFK just announced the latest autism rates in 8 year old children.🚨
1 in 36 have autism.
1 in 20 boys have autism.
1 in 12.5 boys in California have autism.
California has the strictest vaccination laws in the country. Make of that what you will.
<a href="https://t.co/rHuYhqJJOG">pic.twitter.com/rHuYhqJJOG</a>
— Sara Gonzales (@SaraGonzalesTX) <a href="https://twitter.com/SaraGonzalesTX/status/1912555230245408792?ref_src=twsrc%5Etfw">April 16, 2025</a></blockquote>
The CEO of Kenvue, which makes Tylenol, reportedly had a “hastily scheduled meeting” with Kennedy last week over reports about the announcement. Perry argued in the private meeting that there is no causal link between Tylenol use during pregnancy and autism. He argued to Kennedy that Tylenol is a safe option for pregnant women, especially if they spike a fever, and added that other options do have links to birth defects.
Since early September, Kenvue stock has <a href="https://economictimes.indiatimes.com/news/international/us/trump-admin-report-linking-tylenol-to-autism-sends-kenvue-stock-sliding/articleshow/124049521.cms?utm_source=chatgpt.com&amp;from=mdr">dropped</a> around 15%.
When Kennedy first announced that he’d be researching the spike in autism rates, there was notable outrage from the medical establishment, legacy media, and some Democrats. They argued that Kennedy was merely pushing his “anti-vax” views and promulgating dangerous misinformation.
Even some autism organizations were unhappy. They <a href="https://autismsociety.org/statement-on-robert-f-kennedy-jr-s-comments-regarding-the-cause-of-autism-and-misleading-deadline/">condemned</a> Kennedy’s remarks, calling them “harmful, misleading, and unrealistic” and said the spike in autism cases is mostly due to better screening and diagnosis.

President Trump Participates In Swearing-In Ceremony For Medicare and Medicaid Services Administrator Dr. Mehmet Oz

‘I Think We’ve Found An Answer To Autism’: What To Know About Trump’s Major Announcement

The Advisory Committee on Immunization Practices (ACIP) — a highly influential Centers for Disease Control and Prevention (CDC) vaccine panel — held discussions and votes over the past two days on a number of vaccinations.
Specifically, the CDC panel discussed the MMRV, hepatitis B, and COVID vaccines.
On the MMRV vaccine, which protects against measles, mumps, rubella, and chickenpox, the panel voted to delay the shot until a child is at least four years old, citing an increased risk in febrile seizures. It&#8217;s still currently recommended that the MMR and chickenpox vaccine, separately, be given to young children.
The hepatitis B shot was also widely discussed, but ultimately a vote to delay the first dose, which is currently given at birth, was kicked for another time. Some advocates say the first dose is not necessary at birth if the mother herself tests negative for the disease, since hepatitis B is transmitted sexually or by blood.
The panel did vote to <a href="https://www.hhs.gov/press-room/acip-recommends-covid19-vaccination-individual-decision-making.html?utm_source=chatgpt.com">recommend</a> all pregnant women be tested for hepatitis B, a test that is covered across all insurance programs, according to Health and Human Services (HHS).
Lastly, the panel took on COVID vaccines. The panel <a href="https://thehill.com/policy/healthcare/5513336-acip-recommends-childhood-vaccine-changes/">recommended</a> that the shot &#8220;be determined by individual decision-making.&#8221; This means there is no longer a broad recommendation for all, but instead, individuals will decide after discussions with providers, including physicians, nurses, and pharmacists, according to HHS.
&#8220;It allows for immunization coverage through all payment mechanisms including entitlement programs such as the Vaccines for Children Program, Children’s Health Insurance Program, Medicaid, and Medicare, as well as insurance plans through the federal Health Insurance Marketplace,&#8221; HHS adds.
During this latest meeting, five new appointees were named to ACIP: Catherine M. Stein, Dr. Evelyn Griffin, Hilary Blackburn, Dr. Kirk Milhoan, and Dr. Raymond Pollak.
ACIP is highly influential. The panel meets a few times a year and makes recommendations to the CDC, thereby basically setting the childhood vaccine schedule and other vaccine-related recommendations, like flu shots and COVID vaccines. ACIP also heavily influences which vaccines are covered by both public and private insurance.
Back in June, HHS Secretary Robert F. Kennedy Jr. dismissed all sitting ACIP panel members over what he said were conflicts of interest. At the time, Kennedy argued in an op-ed for the Wall Street Journal that ACIP had lost the trust of the American people, effectively becoming a “rubber-stamp” for all vaccines while ignoring safety concerns and conflict of interest rules.
He said that ACIP had “never recommended against a vaccine—even those which were later withdrawn for safety reasons,” adding that the panel “failed to scrutinize vaccine products given to babies and pregnant women.”
Related: <a href="https://www.dailywire.com/news/maha-changes-are-coming-to-mcdonalds?author=Amanda+Prestigiacomo&amp;category=News&amp;elementPosition=0&amp;row=0&amp;rowType=Vertical+List&amp;title=MAHA+Changes+Are+Coming+To+McDonald’s">MAHA Changes Are Coming To McDonald’s</a>

Democratic Presidential Candidate Robert F. Kennedy Jr. Delivers Address To Jewish Community In New York

Vax Panel Takes On COVID, Hep B, And MMRV Vaccines. Here’s What They Decided.

COVID-19 Vaccine

Vaccines

Menu